CABALETTA BIO, INC. (CABA) Operating income 2018–2025
CABALETTA BIO, INC. (CABA) annual operating income history from SEC filings — each fiscal year as reported.
-$172.2MFY2025 · since FY2018: -$6.2M → -$172.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$172.2M | -37.6% |
| FY2024 | -$125.1M | -67.6% |
| FY2023 | -$74.7M | -37.9% |
| FY2022 | -$54.1M | -16.9% |
| FY2021 | -$46.3M | -36.9% |
| FY2020 | -$33.8M | -81.1% |
| FY2019 | -$18.7M | -201.7% |
| FY2018 | -$6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CABA financial trends
CABA RevenueCABA Net incomeCABA Net marginCABA Gross profitCABA Gross marginCABA Operating marginCABA Operating cash flowCABA Free cash flowCABA Capital expendituresCABA Return on equityCABA Stock buybacksCABA Dividends paidCABA Total assetsCABA Total liabilitiesCABA Shareholders’ equityCABA overview →